Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In an in vitro EpiDerm assay conducted in accordance with OECD guideline 431 and to GLP, di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) was corrosive to skin and classified as sub-category 1B-and-1C.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.40 (In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch number of test material: 3341/00-F9
- Expiration date of the lot/batch: September 10, 2020
- Purity test date: Certificate of analysis dated September 09, 2019
- Content: 10.94 % Pt
- Form: liquid
- Appearance: amber liquid
Test system:
human skin model
Source species:
other:
Cell type:
non-transformed keratinocytes
Cell source:
other: EpiDermTM (EPI-200-SCT, lot no. 30830) MatTek In Vitro Life Sciences Laboratories
Source strain:
other: Reconstructed human epidermis model
Details on animal used as source of test system:
not applicable
Justification for test system used:
no data
Vehicle:
unchanged (no vehicle)
Details on test system:
EpiDerm is a three-dimensional reconstructed human epidermis model, comprised of non-transformed, human-derived epidermal keratinocytes, which have been cultured to form a multi-layered, highly differentiated model of the human epidermis. It consists of organized basal, spinous and granular layers, and a multi-layered stratum corneum containing intercellular lamellar lipid layers representing main lipid classes analogous to those found in vivo
The test method is based on the premise that corrosive chemicals are able to penetrate the stratum corneum by diffusion or erosion, and are cytotoxic to the cells in the underlying layers. Cell viability is measured by enzymatic conversion of the vital dye MTT into a blue/purple formazan salt that is
quantitative measured after extraction from tissues. Corrosive materials are identified by their ability to decrease cell viability below defined threshold levels.
The test method is based on the SOP MK-24-007-0024 of the validated and regulatory accepted EpidermTM SCT.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
- Amount(s) applied (volume or weight with unit): 50 μL of undiluted test item were applied to the skin model. Two replicate tissues for each treatment (exposure periods) were employed. At the end of the exposure period, the test item was carefully washed from the skin surface with Dulbecco's phosphate buffered saline (DPBS).

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 50 μL sterile water was added to each of the two negative control skin units.

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 μL KOH was added to each of the two positive control skin units.
- Concentration (if solution): 8N solution
Duration of treatment / exposure:
3 minutes or 1 hour (37°C, 5% CO2 and 95% humidity)
Duration of post-treatment incubation (if applicable):
not applicable
Number of replicates:
2
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
3 minute exposure period
Value:
28
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Remarks:
the mean OD of the negative control of 2 tissues was 1.867 and well within the acceptable range of >0.8 to < 2.8
Positive controls validity:
valid
Remarks:
the viability of cells treated with the positive reference item 8.0N KOH was 4.4% of the negative control
Remarks on result:
other: corrosive
Remarks:
Mean relative viability < 50% and > 25% after 3 min exposure, the test item is considered to be corrosive to skin sub-categories 1B and 1C
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
60 minute exposure period
Value:
6.1
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Remarks:
the mean OD of the negative control of 2 tissues was 1.873 and well within the acceptable range of >0.8 to < 2.8
Positive controls validity:
valid
Remarks:
the viability of cells treated with the positive reference item 8.0N KOH was 4.3% of the negative control and well below the 15 cut-off value at the 60-minute exposure
Remarks on result:
other: corrosive
Remarks:
mean relative viability < 15% (60-minute exposure), the test substance is considered to be corrosive to skin
Other effects / acceptance of results:
The standard deviation of all replicates determined (at 20-100% viability) was below the limit of acceptance of 30%. Hence, all acceptance criteria were fulfilled.

The MTT solution containing the test item did not turn blue/purple. This was taken to indicate the test item did not reduce MTT.

The solution containing the test item was a yellow color, therefore additional color correction tissues were incorporated into the testing procedure. However, the results obtained showed that no color interference occurred. It was therefore considered unnecessary to use the results of the color correction tissues for quantitative correction of results or for reporting purposes.

The relative mean viabilities for each treatment group were as follows:

Exposure Period

Percentage Viability

Negative Control

Positive Control

Test Item

3 minute

100*

4.4

28.0

60 minute

100*

4.3

6.1

*The mean viability of the negative control tissues is set at 100%

*The mean viability of the negative control tissues is set at 100%

Interpretation of results:
other: sub-category 1B and 1C since this test cannot resolve between the two
Conclusions:
In an in vitro EpiDerm assay conducted in accordance with OECD guideline 431 and to GLP, Di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) was corrosive to skin and classified as sub-category 1B-and-1C.
Executive summary:

Di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) was tested for skin corrosivity potential in an in vitro EpiDerm assay conducted in accordance with OECD guideline 431 and to GLP.

Cell viability was quantitatively measured using the MTT reduction assay with optical density being expressed as a relative percentage of that of the negative control. The mean cell viability following exposure to the test substance was calculated to be greater than25% (28% of the negative controls) after a 3-minute exposure and less than 15% (6.1% of the negative controls) after a 1-hour exposure, and it was therefore considered to be corrosive to skin.

Under the conditions of this assay, Di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution)did not meet the criteria for classification as corrosive category 1A under GHS classification criteria but would be classified as sub-category 1B-and-1C.

Based on the results of this study, the test item should be classified as corrosive to the skin (category 1B) according to EU CLP criteria (EC 1272/2008).

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (corrosive)

Eye irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) was tested for skin corrosivity potential in an in vitro EpiDerm assay conducted in accordance with OECD guideline 431 and to GLP. Cell viability was quantitatively measured using the MTT reduction assay with optical density being expressed as a relative percentage of that of the negative control. The mean cell viability following exposure to the test substance was calculated to be greater than25% (28% of the negative controls) after a 3-minute exposure and less than 15% (6.1% of the negative controls) after a 1-hour exposure, and it was therefore considered to be corrosive to skin. Under the conditions of this assay, di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) did not meet the criteria for classification as corrosive category 1A under GHS classification criteria but would be classified as sub-category 1B-and-1C.

Based on the results of this study, the test item should be classified as corrosive to the skin (category 1B) according to EU CLP criteria (EC 1272/2008).

 

Substances that are corrosive to the skin are considered as leading to serious damage to the eyes. Consequently, no further testing is necessary and di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) should be classified for eye effects in Category 1 according to EU CLP criteria (EC 1272/2008).

Justification for classification or non-classification

Based on the results of this study, the test item should be classified as corrosive to the skin (category 1B) according to EU CLP criteria (EC 1272/2008).

According to ECHA guidance on the application of CLP criteria (ECHA, 2017b), “if a substance or mixture is classified as Skin corrosive Category 1 then serious damage to eyes is implicit…thus, the corrosive substance or mixture is also classified, but the corresponding hazard statement is not indicated on the label and there is no need to proceed with classification for eye effects”.

Di(tetraethylammonium)hexahydroxoplatinate(IV) (aqueous solution) is classified for skin effects as corrosive sub-category 1B. Consequently, the compound is classified for eye effects in Category 1 under EU CLP.